DK1322956T3 - Fremgangsmåde til diagnose af immunologisk födevarefölsomhed - Google Patents

Fremgangsmåde til diagnose af immunologisk födevarefölsomhed

Info

Publication number
DK1322956T3
DK1322956T3 DK01916588T DK01916588T DK1322956T3 DK 1322956 T3 DK1322956 T3 DK 1322956T3 DK 01916588 T DK01916588 T DK 01916588T DK 01916588 T DK01916588 T DK 01916588T DK 1322956 T3 DK1322956 T3 DK 1322956T3
Authority
DK
Denmark
Prior art keywords
food sensitivity
testing
diagnosis
disclosed
diagnosing
Prior art date
Application number
DK01916588T
Other languages
English (en)
Inventor
Kenneth D Fine
Original Assignee
Kenneth D Fine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kenneth D Fine filed Critical Kenneth D Fine
Application granted granted Critical
Publication of DK1322956T3 publication Critical patent/DK1322956T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/971—Capture of complex after antigen-antibody reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01916588T 2000-03-15 2001-03-13 Fremgangsmåde til diagnose af immunologisk födevarefölsomhed DK1322956T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18966800P 2000-03-15 2000-03-15
US22447000P 2000-08-10 2000-08-10
US09/798,557 US6667160B2 (en) 2000-03-15 2001-03-02 Method for diagnosing immunologic food sensitivity
PCT/US2001/007908 WO2001069251A2 (en) 2000-03-15 2001-03-13 Method for diagnosing immunologic food sensitivity

Publications (1)

Publication Number Publication Date
DK1322956T3 true DK1322956T3 (da) 2007-09-10

Family

ID=27392618

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01916588T DK1322956T3 (da) 2000-03-15 2001-03-13 Fremgangsmåde til diagnose af immunologisk födevarefölsomhed

Country Status (10)

Country Link
US (3) US6667160B2 (da)
EP (1) EP1322956B1 (da)
AT (1) ATE361470T1 (da)
AU (1) AU2001243593B2 (da)
CA (1) CA2400968C (da)
DE (1) DE60128249T2 (da)
DK (1) DK1322956T3 (da)
ES (1) ES2283397T3 (da)
IL (2) IL151570A0 (da)
WO (1) WO2001069251A2 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
CU22968A1 (es) * 2000-06-07 2004-07-14 Ct Ingenieria Genetica Biotech Procedimiento para la detección de anticuerpos anti transglutaminasa con utilidad en el diagnóstico de la enfermedad celíaca
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
US6818181B2 (en) * 2001-03-15 2004-11-16 Savyon Diagnostics Ltd. Kit and method for detecting food allergies
US6872540B2 (en) * 2001-10-26 2005-03-29 Techlab, Inc. Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
DK1572127T4 (da) * 2002-02-14 2014-11-24 Univ Leland Stanford Junior Enzymbehandling af fødevarer til cøliaki
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
US7462688B2 (en) * 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
US7202216B2 (en) * 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
WO2003096984A2 (en) * 2002-05-14 2003-11-27 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
US7265093B2 (en) 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
WO2004045392A2 (en) * 2002-11-20 2004-06-03 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic method for celiac sprue
WO2004022713A2 (en) * 2002-09-05 2004-03-18 Techlab, Inc. Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
EP1554580B1 (en) * 2002-10-25 2008-05-14 Techlab, Inc. Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel
GB2424273B (en) * 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
US7579313B2 (en) * 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
US7628985B2 (en) * 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US7563864B2 (en) * 2004-04-26 2009-07-21 Celiac Sprue Research Foundation Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
US7534426B2 (en) * 2004-04-26 2009-05-19 The Board Of Trustees Of The Leland Stanford Junior University Glutenase enzyme assays
RU2636532C2 (ru) 2005-05-27 2017-11-23 Онкиммьюн Лимитед Улучшенные способы иммуноанализа
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
NZ580425A (en) * 2007-03-16 2011-12-22 Univ Leland Stanford Junior Combination enzyme therapy for digestion of dietary gluten
WO2008149364A2 (en) * 2007-06-07 2008-12-11 Sarah Brenner Methods for diagnosing hypersensitivity reactions
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
US8409819B1 (en) * 2008-02-26 2013-04-02 Nestec S.A. Methods to predict risk for celiac disease by detecting anti-flagellin antibody levels
CN102438643B (zh) 2008-11-30 2015-07-01 免疫桑特公司 用于治疗乳糜泻的组合物和方法
HU0900199D0 (en) * 2009-04-01 2009-06-29 Debreceni Egyetem Diagnosis of gluten-induced autoimmune diseases
US10449228B2 (en) 2013-09-10 2019-10-22 Immusant, Inc. Dosage of a gluten peptide composition
WO2016054038A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease
CN107110855A (zh) 2014-11-14 2017-08-29 拜尔梅里科有限公司 Ibs 敏感度测试的组合物、设备以及方法
US20170023585A1 (en) * 2015-04-17 2017-01-26 Kenneth Davin Fine Diagnostic testing for immunologic food sensitivity in animals
US20160305954A1 (en) 2015-04-17 2016-10-20 Kenneth Davin Fine Diagnostic testing for immunologic food sensitivity
CN108700575A (zh) * 2015-12-21 2018-10-23 拜尔梅里科有限公司 偏头痛食物敏感测试的组合物、设备以及方法
JP2018538545A (ja) * 2015-12-21 2018-12-27 バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． 乾癬食物感受性試験のための組成物、装置、および方法
CN116183928A (zh) * 2016-04-26 2023-05-30 拜尔梅里科有限公司 溃疡性结肠炎敏感测试的组合物、设备以及方法
WO2017218546A1 (en) * 2016-06-13 2017-12-21 Biomerica, Inc. Compositions, devices, and methods of gastroesophageal reflux disease sensitivity testing

Also Published As

Publication number Publication date
IL151570A0 (en) 2003-04-10
AU2001243593B2 (en) 2006-05-04
US20010036639A1 (en) 2001-11-01
EP1322956A2 (en) 2003-07-02
US20040072272A1 (en) 2004-04-15
WO2001069251A3 (en) 2003-04-17
US6667160B2 (en) 2003-12-23
EP1322956B1 (en) 2007-05-02
WO2001069251A8 (en) 2002-02-07
CA2400968C (en) 2009-06-30
ES2283397T3 (es) 2007-11-01
WO2001069251A2 (en) 2001-09-20
US7604957B2 (en) 2009-10-20
US20070298447A1 (en) 2007-12-27
DE60128249D1 (de) 2007-06-14
IL151570A (en) 2010-05-31
CA2400968A1 (en) 2001-09-20
DE60128249T2 (de) 2008-01-03
ATE361470T1 (de) 2007-05-15

Similar Documents

Publication Publication Date Title
DK1322956T3 (da) Fremgangsmåde til diagnose af immunologisk födevarefölsomhed
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
NO982156L (no) Diagnostisk pr°veinnretning
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
WO2002046746A3 (en) Method for detection of vitamin d metabolites
EP1318399A3 (en) Passive sample detection to initiate timing of an assay
WO2004083859A8 (en) Agglutination based sample testing device
DE60319230D1 (de) Selbst-kalibrierendes system für magnetisches bindungs-verfahren
DK0528525T3 (da) Assaymetoder og sammensætninger til påvisning af serumproteaser, især aktiveret protein C
EP1381864A4 (en) DETECTION OF CANDIDA
WO2004048600A3 (en) Diagnostic tests and methods for diagnosing inflammatory bowel disease
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
WO2003081236B1 (en) Method and device for predicting cardiovascular events
CA2464466A1 (en) Method and apparatus for distinguishing crohn's disease from ulcerative colitis by detecting fecal antibodies to saccharomyces cerevisiae
Li et al. Component resolved diagnostic study of cow's milk allergy in infants and young children in northern China
WO2008063663A3 (en) Poly (ethylene glycol) anti-body detection assays and kits for performing thereof
HUP0201087A2 (hu) Hepatitisz-C antigén-antitest kombinációs vizsgálati eljárás a fertőzés korai kimutatására
ATE240522T1 (de) Chemilumineszenz-immunoassay zum nachweis eines mit der chagas-erkränkung verbundenen analyts in einer probe
MXPA02012176A (es) Un metodo para detectar un complejo de liproproteina -proteina de fase aguda y predecir un riesgo mayor de falla de sistema o mortalidad.
DK1141710T3 (da) Fremgangsmåde til detektering og/eller kvantificering af et specifikt IgE-antistof i en væskepröve
WO2001027621A3 (en) Competitive inhibition elisa for antibody detection
WO2002018931A3 (de) Lösung zur aufbereitung von stuhlproben für diagnostische zwecke
ATE337554T1 (de) Verfaren zur diagnose von neoplasmen
CA2409208A1 (en) Method for examining wt1-related disease
DK1192469T3 (da) Assay